查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378470

脫髮症治療市場：按藥物類別、疾病途徑、配銷通路和地區

Alopecia Treatment Market, By Drug Class, By Disease Type, By Route of Administration, By Distribution Channel, By geography
出版日期: | 出版商: Coherent Market Insights | 英文 193 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年，全球脫髮症治療市場規模將達到96.5億美元，預測期內（2023-2030年）年複合成長率為5.6%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 96.5億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 5.60% 2030年市場規模預測 141.6億美元
圖 1. 2023 年脫髮症治療的全球市場佔有率(%)（依藥物類別）
脫髮治療市場-IMG1

脫髮症是醫學術語，用於描述身體正常毛髮所在區域的毛髮部分或完全脫落。這種情況會影響頭皮、眉毛、睫毛、鬍鬚或身體其他毛髮生長的部位。脫髮症可以是暫時的，也可以是永久性的，由多種因素引起，包括遺傳傾向、荷爾蒙變化、自體免疫疾病、醫學治療以及某些環境和心理因素。脫髮症有多種類型，每種類型都有不同的特徵和根本原因。這些包括脫髮症（以斑狀脫髮為特徵）、雄性脫髮症（俗稱雄性禿或女性型脫髮症）、毛細血管擴張性脫髮（突然、廣泛的脫髮症）和牽引性脫髮症（由於反覆拉扯或拉緊頭髮而引起） ）。

市場動態

市場上的主要企業都專注於內部成長策略，例如脫髮症資金籌措，預計這將在預測期內推動全球脫髮症治療市場的成長。例如，2023 年 7 月，開發可溶性CD83（sCD83）治療脫髮症的生物製藥公司 Mallia Therapeutics GmbH 宣布已獲得種子資金。該公司計劃根據 2023 年 6 月在英國謝菲爾德舉行的第 20 屆歐洲頭髮研究協會 (EHRS) 上公佈的臨床前和體外人體資料開發其 sCD83 候選藥物。 Mallia Therapeutics GmbH 正在開發 sCD83 的雙重作用模式，用於治療荷爾蒙誘導的雄性脫髮症和自體免疫導的雄性脫髮症。此外，增加脫髮症治療的研發活動預計將在預測期內推動全球脫髮症治療市場的成長。例如，2022年11月，臨床階段生物技術公司Equillium, Inc.啟動了EQ101的2期開放標籤研究，以評估對中重度脫髮症成人受試者的療效和安全性。考試開始了。該試驗預計將在澳洲多個臨床中心招募約 30 名參與者。

本次測試的主要特點

  • 該報告對全球脫髮症治療市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和複合年度（年複合成長率）。
  • 它還闡明了不同細分市場的潛在收益成長機會，並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球脫髮症治療市場的主要企業。
  • 本研究涵蓋的主要企業包括 Stemson Therapeutics、OliX Pharmaceuticals, Inc、輝瑞 Inc、Aclaris Therapeutics, Inc、Fagron、Follicum AB、Cipla Inc、Arcutis Biotherapeutics、Dr. Reddy's Laboratories Ltd.、Himalaya Wellness Company、Stemson Therapu​​ys、Stemsgratics Company、St NV、Equillium, Inc.、禮來公司、Concert Pharmaceuticals Inc. 和Teva Pharmaceutical Industries Ltd.
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 全球脫髮症治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球脫髮症治療市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 最近的趨勢
  • 合併、收購和合作
  • 法規場景
  • 主要進展
  • PEST分析
  • 波特的分析

第4章 全球脫髮症治療市場-新型冠狀病毒感染疾病（COVID-19）的影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 對需求和供給的影響

第5章 全球脫髮症治療市場，依藥物類別，2018-2030

  • 皮質類固醇
  • 5 AR抑制劑
  • 血管擴張劑
  • 其他

第6章 全球脫髮症治療市場，依疾病類型，2018-2030

  • 脫髮症
  • 雄性脫髮症
  • 牽引脫髮症
  • 其他

第7章 全球脫髮症治療市場，依給藥途徑，2018-2030

  • 塗布
  • 口服
  • 可注射的

第8章 全球脫髮症治療市場，按配銷通路，2018-2030

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 全球脫髮症治療市場，按地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章 競爭形勢

  • 公司簡介
    • Stemson Therapeutics .
    • OliX Pharmaceuticals
    • Pfizer Inc
    • Aclaris Therapeutics
    • Fagron,
    • Follicum AB
    • Cipla Inc.
    • Arcutis Biotherapeutics
    • Dr. Reddy's Laboratories Ltd
    • Himalaya Wellness Company
    • Cosmo Pharmaceuticals NV
    • Equillium, Inc.
    • Eli Lilly and Company
    • Concert Pharmaceuticals Inc
    • Teva Pharmaceutical Industries Ltd.
  • 分析師觀點

第11章章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1847

Global alopecia treatment market is estimated to be valued at US$ 9.65 Bn in 2023, and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 9.65 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.60% 2030 Value Projection: US$ 14.16 Bn
Figure 1. Global Alopecia Treatment Market Share (%), By Drug Class, 2023
Alopecia Treatment Market - IMG1

Alopecia is a medical term that is used to describe the partial or complete loss of hair from areas of the body where hair is normally found. This condition can affect the scalp, eyebrows, eyelashes, beard, or any other part of the body where hair grows. Alopecia can be temporary or permanent, and can occur due to a variety of factors including genetic predisposition, hormonal changes, autoimmune disorders, medical treatments, and certain environmental or psychological factors. There are several types of alopecia, each with distinct characteristics and underlying causes. These include alopecia areata (characterized by patchy hair loss), androgenetic alopecia (commonly known as male-pattern or female-pattern baldness), telogen effluvium (sudden and widespread hair shedding), traction alopecia (caused by repeated pulling or tension on the hair), and others.

Market Dynamics

The key players in operating in the market are focusing on organic growth strategies such as fund raising for alopecia is expected to propel the global alopecia treatment market growth over the forecast period. For instance, in July 2023, Mallia Therapeutics GmbH, a biopharmaceutical company that is developing soluble CD83 (sCD83) for the treatment of hair loss, announced that it had secured its seed financing. The company plans to develop the sCD83 candidate based on preclinical and ex vivo human data, presented at the 20th meeting of the European Hair Research Society (EHRS) held in Sheffield, UK, in June 2023. sCD83 can be applied topically to reach the hair follicle, which is a big advantage as compared to systemic treatment options. Mallia Therapeutics GmbH develops the dual mode of action of sCD83 for the treatment of hormone-induced male or female pattern baldness (= androgenetic alopecia) and autoimmune mediated male or female patchy hair loss (= alopecia areata), the two most prevalent forms of hair loss. Moreover, increasing research and development activities for alopecia treatment is expected to drive global alopecia treatment market growth over the forecast period. For Instance, In November 2022, Equillium, Inc., a clinical-stage biotechnology company, announced that it had initiated a Phase 2 open-label study of EQ101 to assess efficacy and safety in adult subjects with moderate to severe alopecia areata. The study is expected to enroll approximately 30 subjects at multiple clinical sites in Australia.

Key features of the study:

  • This report provides an in-depth analysis of the global alopecia treatment market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global alopecia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy's Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global alopecia treatment market

Detailed Segmentation:

  • Global Alopecia Treatment Market, By Drug Class:
    • Corticosteroids
    • 5 AR Inhibitors
    • Vasodilators
    • Others
  • Global Alopecia Treatment Market, By Disease Type:
    • Alopecia Areata
    • Androgenic Alopecia
    • Traction Alopecia
    • Others
  • Global Alopecia Treatment Market, By Route of Administration:
    • Topical
    • Oral
    • Injectable
  • Global Alopecia Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Alopecia treatment Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Stemson Therapeutics .
    • OliX Pharmaceuticals, Inc
    • Pfizer Inc
    • Aclaris Therapeutics, Inc.
    • Fagron
    • Follicum AB
    • Cipla Inc.,
    • Arcutis Biotherapeutics
    • Dr. Reddy's Laboratories Ltd.,
    • Himalaya Wellness Company
    • Stemson Therapeutics
    • Cosmo Pharmaceuticals N.V.
    • Equillium, Inc.
    • Eli Lilly and Company
    • Concert Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Disease Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Recent Trends
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • PORTER's Analysis

4. Global Alopecia Treatment Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Alopecia Treatment Market, By Drug Class, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • 5 AR Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Vasodilators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

6. Global Alopecia Treatment Market, By Disease Type, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Alopecia Areata
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Androgenic Alopecia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Traction Alopecia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Alopecia Treatment Market, By Route of Administration, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

8. Global Alopecia Treatment Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

9. Global Alopecia Treatment Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • North America
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018 - 2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Stemson Therapeutics .
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • OliX Pharmaceuticals
    • Pfizer Inc
    • Aclaris Therapeutics
    • Fagron,
    • Follicum AB
    • Cipla Inc.
    • Arcutis Biotherapeutics
    • Dr. Reddy's Laboratories Ltd
    • Himalaya Wellness Company
    • Cosmo Pharmaceuticals N.V.
    • Equillium, Inc.
    • Eli Lilly and Company
    • Concert Pharmaceuticals Inc
    • Teva Pharmaceutical Industries Ltd.
  • Analysts' Views

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact